Wuhan Wansheng Biotechnology: difference between revisions
Diff·revision 23 → 24·23:26, 22 Oct 2024
Difference between revision 23 and revision 24 of Wuhan Wansheng Biotechnology. 8 lines changed; the page grew by 412 bytes.
| Revision 23 — 15:41, 17 Oct 2024 VerifyVesna (talk) add PMID 5,287 bytes ±0 | Revision 24 — 23:26, 22 Oct 2024 UnderfillUna (talk) split overlong sentence 5,699 bytes +412 | ||
|---|---|---|---|
| 32 | No incorporation record, certification or facility description is corroborated by any source available to this wiki, and the article makes no statement about any of them.{{r|selfpub}} | 32 | No incorporation record, certification or facility description is corroborated by any source available to this wiki, and the article makes no statement about any of them.{{r|selfpub}} |
| 33 | 33 | ||
| + | 34 | == Product range == | |
| + | 35 | | Class | Representative listings | Documentation reported | | |
| + | 36 | |---|---|---| | |
| + | 37 | | Incretin analogues | Semaglutide, tirzepatide, retatrutide | Certificate, content varies widely | | |
| + | 38 | | Research peptides | Repair, secretagogue, cosmetic peptides | Certificate, content varies | | |
| + | 39 | | SARMs | Bulk and capsuled | Certificate, purity | | |
| + | 40 | | Injectable and raw materials | Bulk | Certificate, limited detail | | |
| + | 41 | ||
| 34 | == References == | 42 | == References == |
| 35 | {{reflist}} | 43 | {{reflist}} |